deferasirox has been researched along with salicylaldehyde isonicotinoyl hydrazone in 1 studies
| Studies (deferasirox) | Trials (deferasirox) | Recent Studies (post-2010) (deferasirox) | Studies (salicylaldehyde isonicotinoyl hydrazone) | Trials (salicylaldehyde isonicotinoyl hydrazone) | Recent Studies (post-2010) (salicylaldehyde isonicotinoyl hydrazone) |
|---|---|---|---|---|---|
| 832 | 136 | 572 | 44 | 0 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franz, KJ; Hašková, P; Jansová, H; Jirkovská, A; Kielar, F; Macháček, M; Potůčková, E; Simůnek, T; Wang, Q | 1 |
1 other study(ies) available for deferasirox and salicylaldehyde isonicotinoyl hydrazone
| Article | Year |
|---|---|
Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.
Topics: Aldehydes; Animals; Apoptosis; Benzoates; Boron Compounds; Boronic Acids; Cell Line; Cell Membrane Permeability; Cytoprotection; Deferasirox; Hydrazones; Hydrogen Peroxide; Iron; Iron Chelating Agents; Isonicotinic Acids; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Semicarbazones; Triazoles | 2014 |